Dr. Charles Mok argues that low testosterone is underdiagnosed in men and that TRT is affordable and prescribable outside insurance. He claims it may reduce cardiac mortality and extend life by about 10% in affected men, urging doctors not to avoid treatment based on coverage assumptions.
Chapters
There's a whole large group of men that don't have those symptoms and don't have such severely low testosterone. And today, 99% of them aren't being treated, maybe higher percentage than that. So this is a big say, disservice to men in our country for a drug that's pretty cheap, that you could pay for on your own, that your doctor can prescribe, that reduces cardiac mortality substantially, may extend your life about 10% in men with low testosterone. So I think this is something we really need to realize that as physicians, we're under diagnosing testosterone, low testosterone, because the assumption that the insurance company doesn't pay, in other words, if it's not free, men can't have it. You can get stuff that's not covered by insurance. Your doctor is totally allowed to prescribe it in the right setting.